Foundation Medicine has appointed Steven Kafka chief business officer, a newly created position. He joins the company from Aileron Therapeutics, where he served as chief operating officer and chief financial officer. Previously, he was vice president of finance for Infinity Pharmaceuticals and senior director of finance at Millennium Pharmaceuticals.
Sanford-Burnham Medical Research Institute said this week that CEO John Reed is leaving his post at the institute to become head of Roche Pharma Research and Early Development and to serve on the firm's corporate executive committee. Sanford-Burnham's current President, Kristiina Vuori, will take over Reed's responsibilities on an interim basis while the institute seeks his replacement.